KHKewu Huang

Kewu Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kewu Huang has a total of 284 co-authors. Here are the top co-authors by number of shared publications:

  • Ying Wang

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

    10 shared publications
  • Hong Zhang

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China

    7 shared publications
  • Meishan Liu

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, PR China

    7 shared publications
  • Meishan Liu

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China

    7 shared publications
  • Wei Wang

    Department of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China

    7 shared publications
  • Yan Li

    Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Otorhinolaryngology, Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing Key Laboratory of Nasal Diseases, Beijing, China

    7 shared publications

Latest Publications

  • Open Access

    Prognostic value of blood-cell-derived composite inflammatory indices in hospitalized patients with acute exacerbation of bronchiectasis: a single-center retrospective cohort study

    by Huijuan Wang, Yangyu Chen, Yining Zhang, Kewu Huang, Li An

    Background: Acute exacerbation of bronchiectasis (AEB) is closely linked to prolonged hospitalization, intensive care unit (ICU) admission and recurrent readmission. Several blood-cell-derived inflammatory indices, including Neutrophil to lymphocyte ratio (NLR), Platelet to Lymphocyte Ratio (PLR), Systemic Inflammatory Response Index (SIRI), Systemic Immune Inflammation index (SII) and Pan immune Inflammation Value (PIV) have shown prognostic potential in respiratory diseases, yet comparative evidence in large AEB cohorts remains insufficient. Objective: To compare the prognostic performance of NLR, PLR, SIRI, SII andPIV for hospital-related adverse outcomes in hospitalized AEB patients. Methods: This single-center retrospective study enrolled 3,116 hospitalized patients with AEB. Data were extracted from electronic medical records. The primary endpoint was length of hospital stay (LOS), while secondary endpoints included ICU admission and 1-year readmission. Spearman correlation, multivariable regression analyses, receiver-operating-characteristic (ROC) curves, Kruskal–Wallis H test, and Cochran-Armitage trend test were applied. Results: The median age was 61 years and 56.68% of participants were female. ICU admission and 1-year readmission rates were 2.44% and 42.97%, respectively. NLR correlated with LOS ( ρ = 0.258, P < 0.001). After adjustment, each 1-standard-deviation (SD) increase in NLR was associated with a 13.9% longer hospital stay (1.139, 95%CI 1.122–1.156). All five indices were associated with ICU admission (per-SD ORs 1.17–1.61) and INR had highest predictive accuracy (AUC = 0.782, bootstrap-corrected 0.779). All five were also associated with 1-year readmission, though discrimination was low (AUC < 0.62), with PIV the weakest. A dose-response trend across NLR quartiles was evident. CRP correlated with NLR ( ρ = 0.506, 0.411) and LOS ( ρ = 0.199, 0.132) but, being incompletely recorded, were analyzed by correlation only and were not entered into adjusted models. Time-period stratified analyses (2014–2018 vs. 2019–2024) yielded directionally consistent results. Conclusions: NLR exhibits superior prognostic performance compared with PLR, SIRI, SII, and PIV in AEB patients. As a cost-effective and readily available biomarker, NLR is well-suited for in-hospital risk stratification of AEB patients, with associations robust to time-period stratification.

  • Open Access

    Impact of Severe Vitamin D Deficiency on Antibiotic Use in Hospitalized COPD Patients with Exacerbations: A Retrospective Analysis

    by Boyu Li, Meishan Liu, Bingqing Ren, Han Wu, Yi Zhang, Zhuoling An, Kewu Huang

    Background: Exacerbations of chronic obstructive pulmonary disease (ECOPD) often require antibiotic treatment. Vitamin D deficiency has been implicated in influencing the outcomes of ECOPD; however, its role in antibiotic usage during hospitalization remains unclear. Patients and Methods: We conducted a retrospective analysis of 125 hospitalized ECOPD patients, stratified into two groups based on the presence of severe vitamin D deficiency (SVDD, 25-hydroxyvitamin D < 10 ng/mL) and non-severe vitamin D deficiency (NSVDD). Clinical outcomes, including duration of antibiotic treatment, cumulative defined daily doses (cDDDs), hospital length of stay (LOS) and associated costs, were compared between subgroups. Multivariate linear regression was used to assess the association between 25-hydroxyvitamin D levels and antibiotic use, adjusting for demographic and clinical variables. Results: Patients with SVDD exhibited significantly longer durations of antibiotic use (13.50 vs. 11.00 days, P=0.023), higher cDDDs (16.16 vs. 12.00, P=0.012) and longer LOS (15.00 vs .12.00, P=0.026) compared to those with NSVDD. Patients with SVDD and pneumonia had more antibiotics use, longer LOS and higher cost than those with NSVDD and AECOPD (P< 0.05). Multivariate linear regression analysis revealed that lower 25-hydroxyvitamin D levels were independently associated with increased antibiotic duration (coefficient − 0.20, 95% CI − 0.32, − 0.08, P< 0.001) and higher cDDDs (coefficient − 0.24, 95% CI − 0.46, − 0.01, P=0.041) after adjustment, although the magnitude was smaller than that observed for some other variables. Conclusion: SVDD is independently associated with antibiotic burden in hospitalized COPD patients with exacerbation. Prospective studies are warranted to further explore this potential relationship and its clinical implications.

  • Open Access

    Improving Asthma Management Through a Quality Improvement Program: The CARE4ALL Study

    by Kewu Huang, Honglei Shi, Wuhong Zheng, Shaoxiang Huang, Xiaomin Bai, Yanxia Li, Xuhua Lv, Gang Cao, Jinbao Wu, Qun Lin, et al.

  • Open Access

    Effects of T2-high asthma heterogeneity and inhaled corticosteroid on airway and metabolic profiles: A multi-omic approach

    by Yuting Duan, Zhixia Gu, Tingting Liu, Chuan Song, Ying Wang, Wenjun Wang, Ronghua Jin, Xi Wang, Yuanyuan Zhang, Kewu Huang

    Background and Objectives: Asthma represents a heterogeneous chronic respiratory condition. Type 2 (T2) inflammation is the most crucial pathological event in asthma. In terms of whether T2 inflammation is dominant or not, asthma can be classified into T2-high and T2-low asthma. Currently, there exists a significant gap in our understanding of the heterogeneity of treatment-naive T2-high asthma patients. Moreover, no studies have examined the impacts of inhaled corticosteroids (ICS) on the airway microenvironment and metabolism of T2-high asthma during the early stage of treatment. This study, by employing multi-omic techniques, investigated the pathophysiological features and heterogeneity of untreated T2-high asthma, as well as the effects of ICS treatment. This study provided more in-depth insights into the pathophysiological mechanisms underlying T2-high asthma heterogeneity. Methods: Thirty-one treatment-naive T2-high asthma patients and fourteen healthy individuals were enrolled in this study. On the basis of hierarchical clustering analysis of T2 inflammation markers, fractional exhaled nitric oxide (FeNO) level and blood eosinophil count (BEC), the T2-high asthma patients were divided into three subgroups in terms of FeNO levels (≤ 25 ppb, 26-50 ppb, and > 50 ppb). All asthma patients underwent asthma control scoring, pulmonary function tests, and FeNO measurement at baseline and during a regular 3-month follow-up. Induced sputum and plasma were collected. Other tests included 16S rRNA microbiome profiling of the induced sputum, Luminex xMAP immunoassays of cytokines, and plasma metabolomic analysis using Q-Exactive liquid chromatography-mass spectrometry (LC-MS/MS). Meanwhile, data from the healthy population were also harvested. Results: T2-high asthma patients differed significantly from healthy controls in terms of airway inflammatory cytokines, airway microbial community structure, and plasma metabolic profiles. At baseline, T2-high asthma patients with different FeNO levels exhibited remarkable similarities in clinical symptoms, pulmonary function indices, airway cytokines, airway microbial diversity, and metabolites. After treatment with ICS, symptoms improved in T2-high asthma patients. The levels of FeNO, blood eosinophils, and total immunoglobulin E (tIgE) decreased significantly, while pulmonary function did not show substantial improvement. Some indices of airway cytokines underwent changes. No differences were found in airway microbial diversity; however, the abundance of Actinomyces increased. Moreover, the levels of glycerophospholipids and arachidonic acid metabolites decreased. Differentially expressed metabolites were enriched in arachidonic acid metabolism. The effect of ICS treatment varied among different T2-high asthma subgroups. Conclusions: The airway local microenvironment and systemic metabolic profiles of treatment-naive T2-high asthma patients were distinctly different from those of healthy individuals. Limited heterogeneity was observed among patients stratified in terms of T2-inflammatory burden. ICS altered the airway microenvironment and rectified the lipid/arachidonic acid metabolic dysregulation. However, ICS effects varied across various T2-high subgroups.


  • Open Access

    Lymphocyte Profile Analysis in Lymph Node Puncture Fluid of Mediastinal Reactive Lymphadenopathy and Its Value in Differential Diagnosis with Tuberculous Lymphadenitis

    by Song Mi, Na Cui, Jing Wang, Liming Zhang, Kewu Huang

    Background: Lymphocyte profile (LP) analysis in mediastinal lymph nodes for differentiating reactive lymphadenopathy (RL) from tuberculous lymphadenitis (TBLA) remains understudied. Methods: Patients with intrathoracic lymphadenopathy undergoing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) were enrolled. Lymph node puncture fluid (LNPF) was analyzed via flow cytometry to compare LP characteristics between TBLA and RL. Receiver operating characteristic (ROC) analysis identified optimal diagnostic cut-offs, and sensitivity, specificity, and accuracy were calculated. Results: A total of 41 TBLA cases and 45 RL cases were included. Compared with the TBLA group, the RL group exhibited increased proportions of CD4⁺ T cells and B cells, and decreased proportions of CD8⁺ T cells, natural killer (NK) cells, and natural killer T (NKT) cells in LNPF. Among single parameters, the CD4/CD8 ratio demonstrated the highest diagnostic performance for TBLA, with sensitivity of 88.89%, specificity of 70.73%, and accuracy of 80.23%. Among three-parameter combinations, the CD4⁺ T cell, CD8⁺ T cell, and NK cell ratio combination achieved optimal diagnostic performance, with sensitivity of 80.5%, specificity of 86.7%, and accuracy of 82.6%.

  • Open Access

    Validation of the patient health questionnaire (PHQ)-9 and PHQ-2 in patients with COPD in China

    by Meishan Liu, Yuhan Chang, Dong Wang, Jiexin Fang, Shannon Carson, Boyu Li, Yongdong Hu, Kewu Huang

    Patient Health Questionnaire (PHQ-9) and PHQ-2 are commonly used screening tools for depression but have not been validated in Chronic obstructive pulmonary disease (COPD) patients. We aimed to validate PHQ-9 and PHQ-2 among COPD patients in China. Stable COPD patients were assessed using a PHQ-9 questionnaire and then assessed by a senior psychiatrist to confirm the diagnosis of major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Receiver operating characteristic curve analysis was performed to validate the PHQ-9/PHQ-2. Out of 265 COPD patients, 11.7% were diagnosed with MDD. The Cronbach’s α-coefficient for PHQ-9 was 0.751. Both PHQ-9 and PHQ-2 showed good correlations with COPD symptoms and quality of life. The AUC values of PHQ-9 and PHQ-2 were 0.848 and 0.736, respectively, for identifying MDD. Based on the highest Youden index, the optimal cut-off scores were PHQ-9 ≥ 7 and PHQ-2 ≥ 2, with a sensitivity of 74.2% and 58.1% and specificity of 89.7% and 89.3%, respectively. PHQ-9 score ≥ 7 and PHQ-2 score ≥ 2 should be used as the optimal cut-offs for COPD patients in China. PHQ-9 is a valid tool for detecting MDD in COPD patients, while PHQ-2 (score < 2) is more useful for quickly excluding MDD.


  • Open Access

    Demographics, risk factors and prevalence of chronic cough in Asian general adult population: a narrative review

    by Xuwen Yang, Mengjia Hu, Kewu Huang

    Background and Objective: Chronic cough is the most common medical problem for patients presenting to primary and secondary health care bringing a significant disease burden. Asia has the largest population size, with diverse cultures and environments. However, there is no comprehensive report of the prevalence, underlying causes, and disease burden of chronic cough among the general adult population in Asia. We therefore aimed to summarize the epidemiology of chronic cough in Asian general adult population. Methods: A narrative search of PubMed database, the Cochrane Library, and Web of Science was performed by using medical theme title as the main and supplemented by free text words including “chronic cough”, “chronic bronchitis”, “longstanding cough”, “persistent cough”, “epidemiology”, “prevalence”, “risk factor”, “burden”, “adult”, “general population”, and “Asia”. Key Contents and Findings: An increasing number of studies on chronic cough prevalence in Asia focus primarily on East Asia, with limited attention to Central Asia. The prevalence among the general population reported in different regions of Asia varies widely, partly due to the use of variable definitions of chronic cough. Several risk factors for chronic cough have been identified, including age, allergy or asthma, smoking, occupational exposure, and air pollution, however, other possible factors such as ethnicity, sex, body weight, other concomitant diseases, socioeconomic status, education level, and diet remain inconclusive. Even if chronic cough is typically not life-threatening, the physical, psychological, and socioeconomic burden of chronic cough is obvious, especially for older patients or those with more comorbidities. Conclusions: Chronic cough is a common symptom in the Asian general adult population, which is related to several identifiable risk factors and leads to a great disease burden. In future research, there is an urgent need to apply the standard definition of chronic cough, and include some countries or regions to make up for the lack of chronic cough epidemiological data in Asia.


  • Open Access

    Detection of Inadequately Controlled Asthma in Adults Using Impulse Oscillometry and Fractional Exhaled Nitric Oxide

    by Xuwen Yang, Meishan Liu, Honglei Shi, Mengjia Hu, Yong Lu, Xiaohong Chang, Kewu Huang

    Purpose: To investigate the effectiveness of impulse oscillometry (IOS) and its combination with fractional expiratory nitric oxide (FeNO) in distinguishing inadequately controlled asthma (ICA) from well-controlled asthma (WCA) in adults. Patients and Methods: Adult patients aged 18 and above with asthma were recruited and underwent routine blood tests, FeNO, IOS, and spirometry before and after bronchodilator administration on the same day. Asthma control level was assessed using Asthma Control Test (ACT) scores; WCA was defined as a score above 20, while ICA was defined as a score of 20 or below. Receiver operating characteristic curve (ROC) and logistic regression analyses were employed to determine the relationship between IOS and FeNO measurements and asthma control. Results: The z score values of IOS parameters, specifically resistance at 5 hz (R5), resistance at 20 hz (R20), and the area under reactance curve between 5 hz and resonant frequency (AX) after bronchodilator administration were significantly different between the WCA (n = 75) and ICA (n = 77) groups. IOS parameters, R5, R20, and AX, after bronchodilation identified patients with ICA, with areas under receiver operating characteristic curve (AUC) of 0.654, 0.690, and 0.708, respectively, adjusted for smoke exposure, variable airflow limitation and fixed airflow obstruction. Combining IOS parameters with FeNO significantly increased the AUC (0.728, 0.752, and 0.763) for detecting ICA compared to IOS parameters with R5, R20, and AX, alone. Patients with abnormal IOS and FeNO values had significantly higher odds ratio (OR) of having ICA by logistic regression analyses, especially for abnormally higher AX, with an OR of 6.48. Conclusion: IOS is useful in discriminating ICA from WCA in adults, with its effectiveness further enhanced when combined with FeNO measurements.